These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 23445811)

  • 21. Altered Hsp90 function in cancer: a unique therapeutic opportunity.
    Bagatell R; Whitesell L
    Mol Cancer Ther; 2004 Aug; 3(8):1021-30. PubMed ID: 15299085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting extracellular Hsp90: A unique frontier against cancer.
    Sager RA; Khan F; Toneatto L; Votra SD; Backe SJ; Woodford MR; Mollapour M; Bourboulia D
    Front Mol Biosci; 2022; 9():982593. PubMed ID: 36060252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hsp90: a drug target?
    Holzbeierlein JM; Windsperger A; Vielhauer G
    Curr Oncol Rep; 2010 Mar; 12(2):95-101. PubMed ID: 20425593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell surface Cdc37 participates in extracellular HSP90 mediated cancer cell invasion.
    El Hamidieh A; Grammatikakis N; Patsavoudi E
    PLoS One; 2012; 7(8):e42722. PubMed ID: 22912728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heat-shock protein 90 inhibitors as novel cancer chemotherapeutics - an update.
    Neckers L; Neckers K
    Expert Opin Emerg Drugs; 2005 Feb; 10(1):137-49. PubMed ID: 15757409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hsp90 is expressed and represents a therapeutic target in human oesophageal cancer using the inhibitor 17-allylamino-17-demethoxygeldanamycin.
    Wu X; Wanders A; Wardega P; Tinge B; Gedda L; Bergstrom S; Sooman L; Gullbo J; Bergqvist M; Hesselius P; Lennartsson J; Ekman S
    Br J Cancer; 2009 Jan; 100(2):334-43. PubMed ID: 19142186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heat shock protein 90 inhibition depletes LATS1 and LATS2, two regulators of the mammalian hippo tumor suppressor pathway.
    Huntoon CJ; Nye MD; Geng L; Peterson KL; Flatten KS; Haluska P; Kaufmann SH; Karnitz LM
    Cancer Res; 2010 Nov; 70(21):8642-50. PubMed ID: 20841485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of new biomarkers for clinical trials of Hsp90 inhibitors.
    Zhang H; Chung D; Yang YC; Neely L; Tsurumoto S; Fan J; Zhang L; Biamonte M; Brekken J; Lundgren K; Burrows F
    Mol Cancer Ther; 2006 May; 5(5):1256-64. PubMed ID: 16731758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery and development of heat shock protein 90 inhibitors as anticancer agents: a review of patented potent geldanamycin derivatives.
    Kim T; Keum G; Pae AN
    Expert Opin Ther Pat; 2013 Aug; 23(8):919-43. PubMed ID: 23641970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heat-shock protein 90 (Hsp90) as a molecular target for therapy of gastrointestinal cancer.
    Moser C; Lang SA; Stoeltzing O
    Anticancer Res; 2009 Jun; 29(6):2031-42. PubMed ID: 19528462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of heat shock protein 90 impairs epidermal growth factor-mediated signaling in gastric cancer cells and reduces tumor growth and vascularization in vivo.
    Lang SA; Klein D; Moser C; Gaumann A; Glockzin G; Dahlke MH; Dietmaier W; Bolder U; Schlitt HJ; Geissler EK; Stoeltzing O
    Mol Cancer Ther; 2007 Mar; 6(3):1123-32. PubMed ID: 17363505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heat shock protein 90: a unique chemotherapeutic target.
    Cullinan SB; Whitesell L
    Semin Oncol; 2006 Aug; 33(4):457-65. PubMed ID: 16890800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted cancer therapy through 17-DMAG as an Hsp90 inhibitor: Overview and current state of the art.
    Mellatyar H; Talaei S; Pilehvar-Soltanahmadi Y; Barzegar A; Akbarzadeh A; Shahabi A; Barekati-Mowahed M; Zarghami N
    Biomed Pharmacother; 2018 Jun; 102():608-617. PubMed ID: 29602128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HSP90 modulates actin dynamics: inhibition of HSP90 leads to decreased cell motility and impairs invasion.
    Taiyab A; Rao ChM
    Biochim Biophys Acta; 2011 Jan; 1813(1):213-21. PubMed ID: 20883729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Y-632 inhibits heat shock protein 90 (Hsp90) function by disrupting the interaction between Hsp90 and Hsp70/Hsp90 organizing protein, and exerts antitumor activity in vitro and in vivo.
    Wang W; Liu Y; Zhao Z; Xie C; Xu Y; Hu Y; Quan H; Lou L
    Cancer Sci; 2016 Jun; 107(6):782-90. PubMed ID: 27002306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of heat-shock protein 90 on cancer metastasis.
    Tsutsumi S; Beebe K; Neckers L
    Future Oncol; 2009 Jun; 5(5):679-88. PubMed ID: 19519207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of 17-allylamino-17-demethoxygeldanamycin hydroquinone hydrochloride (IPI-504), an anti-cancer agent directed against Hsp90.
    Sydor JR; Normant E; Pien CS; Porter JR; Ge J; Grenier L; Pak RH; Ali JA; Dembski MS; Hudak J; Patterson J; Penders C; Pink M; Read MA; Sang J; Woodward C; Zhang Y; Grayzel DS; Wright J; Barrett JA; Palombella VJ; Adams J; Tong JK
    Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17408-13. PubMed ID: 17090671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HSP90 and Immune Modulation in Cancer.
    Graner MW
    Adv Cancer Res; 2016; 129():191-224. PubMed ID: 26916006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benzoquinone ansamycin heat shock protein 90 inhibitors modulate multiple functions required for tumor angiogenesis.
    Sanderson S; Valenti M; Gowan S; Patterson L; Ahmad Z; Workman P; Eccles SA
    Mol Cancer Ther; 2006 Mar; 5(3):522-32. PubMed ID: 16546966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of Heat Shock Protein 90 suppresses TWIST1 Transcription.
    Chong KY; Kang M; Garofalo F; Ueno D; Liang H; Cady S; Madarikan O; Pitruzzello N; Tsai CH; Hartwich TMP; Shuch BM; Yang-Hartwich Y
    Mol Pharmacol; 2019 Aug; 96(2):168-179. PubMed ID: 31175180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.